Program
Prilocaine
Also written as “Tested Lidocaine and Prilocaine Cream” and “lidocaine and prilocaine”.
Its studies are mostly in Periodontal Diseases, led by 2 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Dentsply Sirona | 10 open or running | phase 4since Jun 24, 2011 | Jun 24, 2011 | none ahead |
| Haisco Pharmaceutical Group | 10 open or running | phase 1since Apr 20, 2026 | Apr 20, 2026 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 24, 2011First study: phase 4 study in Periodontal DiseasesNew to Dentsply SironaDentsply Sirona · NCT01591616 · 16 enrolled · United States
- Apr 20, 2026Haisco Pharmaceutical Group’s first study: phase 1 study in HealthyNew to Haisco Pharmaceutical GroupHaisco Pharmaceutical Group · NCT07551713 · 40 enrolled · China
TargetBeta
“Sodium channel alpha subunit blocker; Sodium channel alpha subunit blocker”ChEMBL 37, by rule
Other programs on the same 10 targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Lidocainerule | Keenova Therapeutics | phase 4 | 63 |
| Lamotriginerule | GlaxoSmithKline | phase 4 | 61 |
| Carbamazepinerule | grin-therapeutics-inc | phase 4 | 21 |
| Dronedaronerule | Sanofi | phase 4 | 18 |
| chloroprocainerule | sintetica-sa | phase 4 | 8 |
| Riluzolerule | Sanofi | phase 4 | 6 |
| Carticainerule | Laboratoires Thea | phase 4 | 1 |
| Ropivacainerule | painreform-ltd | phase 3 | 17 |
| Phenytoinrule | Viatris | phase 3 | 10 |
| rufinamiderule | Eisai | phase 3 | 7 |
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07551713Healthy · China | 1 | Completed | Haisco Pharmaceutical Group | Jul 10, 2020 | 40 |
| NCT01591616Periodontal Diseases · United States | 4 | Completed | Dentsply Sirona | Apr 2012 | 16 |
How it is read
Names in the registry
- “Tested Lidocaine and Prilocaine Cream”, 1 entry
- “lidocaine and prilocaine”, 1 entry
Conditions, from the studies’ own filings
- Periodontal Diseases, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.